| 标题 |
A Randomized Controlled Trial of Rituximab for Severe Idiopathic Membranous Nephropathy (IMN)
|
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | Methods: Patients with biopsy proven IMN and persistent nephrotic syndrome after 6 months despite Non Immunosuppressive Antiproteinuric Treatment (NIAT) were randomly assigned to 6-month therapy with NIAT and 375 mg/m2 of rituximab on days 1 and 8, or NIAT alone. |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |